Safety Surveillance Principal Specialist (Søborg, Capital Region of Denmark, DK)
About this opportunity
.
Your impact begins here
As Safety Surveillance Principal Specialist, you will be the safety lead for several products in Novo’s early pipeline, working where non-clinical and clinical development meet. You will turn emerging data into a clear early safety profile and shape decisions for first-in-human and early clinical studies. Your scientific judgement will help protect the people taking part in these studies and give development teams the clarity to move at pace.
What you’ll bring
You are a scientist first. You are confident, outgoing and driven, and you want to be in the room where early safety decisions are made.
A PhD, MD, DVM, MSc Pharm or equivalent in Medicine or Natural Sciences, with extensive experience in pharmacovigilance or early-phase pharmaceutical development.
A solid understanding of drug development processes, global regulatory requirements and GxP standards.
A strong grasp of medical concepts, disease mechanisms and scientific methodology. You use data to build scientific understanding, rather than letting the data lead you.
The ability to identify challenges, shape strategies and turn them into clear, actionable steps.
Confidence to take informed scientific risks and make a call, while never compromising on patient safety.
Excellent collaboration and communication skills, with the ability to guide and influence others through mentorship and informal leadership.
A self-driven, ethical and adaptable approach. You work independently, address issues proactively and stay flexible when priorities change.
What you’ll do
Own the early safety profile of products, evaluating emerging pre-clinical and clinical safety data to guide patient surveillance and business decisions.
Lead the resolution of complex safety challenges and provide strong scientific and medical input across development activities.
Shape study designs, clinical protocols and benefit-risk assessments, working to ambitious development timelines.
Chair a cross-functional drug safety committee and represent Safety Surveillance in key cross-functional teams.
Drive initiatives that strengthen scientific, strategic and operational excellence within Safety Surveillance.
Who you’ll work with
You will join Safety Surveillance Early Development, part of Global Patient Safety in Research & Development. It is a team of 8 colleagues in Denmark, and it handles all First Human Dose (FHD) studies across all indications at Novo. The team provides scientific safety expertise to early-stage projects, contributes to safety strategy and supports protocol review, risk assessments, early signal detection and cross-functional safety forums.
Your closest partners will be the non-clinical project manager, the medical specialist and the clinical pharmacologist. Together you will design studies that are scientifically strong and move quickly. You will also work with skilled colleagues across Non-clinical and Clinical Development, and across several therapeutic areas.
The environment is dynamic, collaborative and highly engaged. Colleagues share scientific insights, speak openly and support one another when evaluating complex safety data. Everyone is focused on doing what is best for the people we serve.
What you can expect here
You will have real ownership. As safety lead, you will be trusted to work independently, make your voice heard and influence decisions that guide early development. You will keep learning from colleagues across Non-clinical and Clinical Development, and you will help strengthen a culture of knowledge sharing and openness in the team.
Salary: For this role, the Annual Base Salary ranges from 847,000 to
1,245,100 DKK, corresponding to the level of the position. The placement within the salary range will be assessed during the recruitment process based on the candidate's skills, competencies, knowledge and relevant experience.
Incentives and Benefits : The salary package may include short-term and/or long-term incentives as well as other employee benefits based on position level, location, functional area and relevant market benchmarks.
Learn more about our Reward Philosophy here
Start now
Your impact begins today. Please apply by 25 November 2026. We review applications on an ongoing basis, so we encourage you to apply as soon as possible.
We are an equal opportunities employer and are committed to an inclusive recruitment process and equality of opportunity for all applicants.
Job details
How this role compares
Computed from every other active Pharmacovigilance role in our database, not just this employer's listings.
We currently track 61 comparable Principal Pharmacovigilance roles across 30 biopharma companies.
Salary context
19 of 61 peers report a salary range (USD, annualized)
Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.
Where these roles are based
Top locations among the 61 comparable roles
+ 8 more countries
Seniority mix
61 of 61 peers have a known seniority level
Therapeutic area mix
16 of 61 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden
Similar opportunities
The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.
Notify me about similar jobs
Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.
Or follow a whole field: get every new Pharmacovigilance job in Denmark, and choose locations and companies.
How we calculate "similar"
No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.
Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.
0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.